SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

The “Drop Pop” X account, a satirical parody account that looks similar to actual news accounts, is behind the false claims ...

Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - BOSTON and ...

The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...

This brand offers a bunch of beds, but what should you know about their most popular AS3 mattress before you buy it for ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo ...

Gabbard has been accused of spreading Russian propaganda and former Secretary of State Hillary Rodham Clinton once referred ...